Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone. 1993

G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
Department of Neuroimmunology, Max-Planck-Institute of Psychiatry, Martinsried, FRG.

We have investigated whether the normal immune system contains T cells that are able to recognize T cell receptor (TcR) determinants of autologous autoantigen-specific T cells. The T cell clone HW.BP3, specific for myelin basic protein (MBP) was isolated from a healthy donor. HW.BP3 is restricted by HLA-DR2a, and reacts to human MBP 139-153. The expressed alpha beta TcR genes of HW.BP3 were cloned and sequenced, and the sequences analyzed for potential T cell epitopes. Two synthetic peptides, one from the VDJ beta junctional (beta 1) and one from the V beta region (beta 2) of the TcR of HW.BP3, were used to select four TcR peptide-specific T cell lines from the donor of HW.BP3. All anti-TcR lines had the phenotype CD3+/CD4+/HLA-DR+/CD25+/CD45RO+, and recognized the antigen in the context of HLA-DR. Three anti-TcR lines, which had been selected for reactivity to peptide beta 1, recognized exclusively this peptide restricted by HLA-DR2b. One anti-TcR line, selected for peptide beta 2, responded to both peptides beta 1 and beta 2 when presented by autologous blood mononuclear cells, but not by HLA-DR2a- or HLA-DR2b-transfected L cells. All TcR peptide-specific T cell lines were efficiently cytotoxic. They specifically lysed autologous macrophages or HW.BP3 line cells in the presence of exogenous peptide antigen. In contrast, HW.BP3 did not present endogenous TcR peptides to the anti-TcR lines. The results demonstrate that the normal human immune system contains not only autoantigen-specific T cells, but also T cells that recognize antigenic determinants of autologous autoreactive TcR.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004676 Myelin Basic Protein An abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes. Golli-MBP1 Protein,Golli-MBP2 Protein,HOG5 Protein,HOG7 Protein,MBP1 Protein,MBP2 Protein,MBP3 Protein,MBP4 Protein,Myelin Basic Protein, 17.2 kDa Isoform,Myelin Basic Protein, 18.5 kDa Isoform,Myelin Basic Protein, 20.2 kDa Isoform,Myelin Basic Protein, 21.5 kDa Isoform,Myelin Basic Protein, Isoform 1,Myelin Basic Protein, Isoform 2,Myelin Basic Protein, Isoform 3,Myelin Basic Protein, Isoform 4,Myelin Basic Protein, Isoform 5,Myelin Basic Protein, Isoform 6,Myelin Basic Protein, Isoform 7,Golli MBP1 Protein,Golli MBP2 Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
January 1992, Autoimmunity,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
February 1989, European journal of immunology,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
June 1995, Journal of neuroimmunology,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
September 1995, International immunology,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
May 1998, Immunity,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
April 1992, European journal of immunology,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
February 1993, Cell,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
July 1995, Annals of the New York Academy of Sciences,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
May 1992, European journal of immunology,
G Saruhan-Direskeneli, and F Weber, and E Meinl, and M Pette, and G Giegerich, and A Hinkkanen, and J T Epplen, and R Hohlfeld, and H Wekerle
March 1992, European journal of immunology,
Copied contents to your clipboard!